China Longevity : UPDATE ON SUSPENSION OF TRADING

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

CHINA LONGEVITY GROUP COMPANY LIMITED

中 國 龍 天 集 團 有 限 公 司

(Incorporated in the Cayman Islands with limited liability)

(Stock Code: 1863)

UPDATE ON SUSPENSION OF TRADING

This announcement is made by China Longevity Group Company Limited (the "Company", together with its subsidiaries, the "Group") pursuant to Rule 13.24A of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited (the "Listing Rules"), and the inside information provisions under Part XIVA of the Securities and Futures Ordinance (Chapter 571, Laws of Hong Kong).

Reference are made to the announcements of the Company dated 13 June 2014, 18 September 2017, 1 August 2018, 26 October 2018, 9 November 2018, 11 December 2018, 11 February 2019, 30 April 2019, 18 June 2019, 2 August 2019, 4 November 2019, 3 February 2020 and 12 May 2020 (the "Announcements"). Capitalised terms used herein shall have the same meanings as those defined in the Announcements.

BUSINESS UPDATE

The Board would like to update the shareholders of the Company that the Company's production operation and financials remain healthy and will continue to focus on the research and development of new materials and products.

SUSPENSION OF TRADING

The shares of the Company have been suspended from trading on The Stock Exchange of Hong Kong Limited ("Stock Exchange") since 14 February 2013.

As previously provided under the Company's Announcement on 18 June 2019, the Stock Exchange has confirmed that it will, until further notice, withhold exercising its right to delist the Company under Rule 6.01A(2)(b)(ii) should the trading in the Company's securities remain suspended on 31 July 2019.

- 1 -

As of the date of this announcement, the Company has not received any notice from the Stock Exchange stating that it is proceeding to delist the Company.

THE REGULATORY CONCERNS OF THE SFC

On 23 December 2019, the Company, upon suggestion of the Securities and Futures Commission ("the Commission"), submitted a written representation to the Board of the Commission ("the Board") pursuant Section 9 of the Securities and Futures (Stock Market Listing) Rules ("SMLR") addressing the concerns raised by the Commission in its "Show Cause Letter" dated 24 November 2014 ("the Resumption Application").

Pursuant to the letter from the Commission Secretary to the Enforcement Division of the Commission ("ENF") dated 8 May 2020, the Company was informed that the Board has considered the Resumption Application during the Commission meeting held on 7 May 2020. The said meeting was adjourned in order to seek clarification on several questions raised by the Board and will resume to further consider the Resumption Application following receipt of the written answers to the questions to be provided by the ENF. The Company understands that up to the date hereof, the Board has not made a decision on the Resumption Application yet and may seek further information as it deems appropriate in order to enable it to do so.

The Company will make further announcement(s) to keep the Shareholders informed and updated with the latest development as and when appropriate.

Trading of shares of the Company has been suspended since 14 February 2013 and will remain suspended until further notice.

By order of the Board

China Longevity Group Company Limited

Lin Shengxiong

Executive Director

Hong Kong, 31 July 2020

As at the date of this announcement, the Board comprises three executive Directors, namely Mr. Lin Shengxiong, Mr. Huang Wanneng and Mr. Jiang Shisheng, and three independent non-executive Directors are Mr. Lau Chun Pong, Mr. Lu Jiayu and Ms. Jiang Ping.

- 2 -